
Assam Entrade Limited (ASSAMENT.BO) Stock Competitors & Peer Comparison
See (ASSAMENT.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Investment - Banking & Investment Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ASSAMENT.BO | ₹661.95 | +10.14% | 907.7M | 31.44 | ₹20.05 | N/A |
| JMFINANCIL.NS | ₹128.97 | +4.34% | 117B | 10.24 | ₹11.94 | +2.66% |
| JMFINANCIL.BO | ₹128.75 | +3.96% | 116.7B | 9.75 | ₹12.56 | +2.66% |
| IIFLCAPS.BO | ₹339.65 | +0.55% | 105.3B | 14.34 | ₹23.56 | +0.89% |
| MEDIASSIST.NS | ₹366.10 | +0.97% | 27.5B | 25.94 | ₹14.17 | N/A |
| AQFINTECH.BO | ₹1,226.85 | -0.16% | 19.2B | 1095.40 | ₹1.12 | N/A |
| MIIL.BO | ₹719.80 | -0.55% | 15.7B | 1902.11 | ₹0.38 | +0.01% |
| AKCAPIT.BO | ₹1,761.95 | -1.01% | 11.7B | 17.12 | ₹103.65 | +2.93% |
| LKPFIN.BO | ₹175.00 | +4.17% | 10.8B | -532.66 | -₹0.32 | N/A |
| GCSL.BO | ₹429.15 | +2.42% | 9.7B | 36.13 | ₹11.87 | +0.11% |
Stock Comparison
ASSAMENT.BO vs JMFINANCIL.NS Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, JMFINANCIL.NS has a market cap of 117B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while JMFINANCIL.NS trades at ₹128.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas JMFINANCIL.NS's P/E ratio is 10.24. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to JMFINANCIL.NS's ROE of +0.12%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to JMFINANCIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check JMFINANCIL.NS's competition here
ASSAMENT.BO vs JMFINANCIL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, JMFINANCIL.BO has a market cap of 116.7B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while JMFINANCIL.BO trades at ₹128.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas JMFINANCIL.BO's P/E ratio is 9.75. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to JMFINANCIL.BO's ROE of +0.12%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to JMFINANCIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check JMFINANCIL.BO's competition here
ASSAMENT.BO vs IIFLCAPS.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, IIFLCAPS.BO has a market cap of 105.3B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while IIFLCAPS.BO trades at ₹339.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas IIFLCAPS.BO's P/E ratio is 14.34. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to IIFLCAPS.BO's ROE of +0.21%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to IIFLCAPS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check IIFLCAPS.BO's competition here
ASSAMENT.BO vs MEDIASSIST.NS Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, MEDIASSIST.NS has a market cap of 27.5B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while MEDIASSIST.NS trades at ₹366.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas MEDIASSIST.NS's P/E ratio is 25.94. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to MEDIASSIST.NS's ROE of +0.14%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to MEDIASSIST.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check MEDIASSIST.NS's competition here
ASSAMENT.BO vs AQFINTECH.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, AQFINTECH.BO has a market cap of 19.2B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while AQFINTECH.BO trades at ₹1,226.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas AQFINTECH.BO's P/E ratio is 1095.40. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to AQFINTECH.BO's ROE of +0.12%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to AQFINTECH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check AQFINTECH.BO's competition here
ASSAMENT.BO vs MIIL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, MIIL.BO has a market cap of 15.7B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while MIIL.BO trades at ₹719.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas MIIL.BO's P/E ratio is 1902.11. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to MIIL.BO's ROE of +0.41%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to MIIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check MIIL.BO's competition here
ASSAMENT.BO vs AKCAPIT.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, AKCAPIT.BO has a market cap of 11.7B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while AKCAPIT.BO trades at ₹1,761.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas AKCAPIT.BO's P/E ratio is 17.12. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to AKCAPIT.BO's ROE of +0.11%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to AKCAPIT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check AKCAPIT.BO's competition here
ASSAMENT.BO vs LKPFIN.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, LKPFIN.BO has a market cap of 10.8B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while LKPFIN.BO trades at ₹175.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas LKPFIN.BO's P/E ratio is -532.66. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to LKPFIN.BO's ROE of +0.06%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to LKPFIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check LKPFIN.BO's competition here
ASSAMENT.BO vs GCSL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, GCSL.BO has a market cap of 9.7B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while GCSL.BO trades at ₹429.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas GCSL.BO's P/E ratio is 36.13. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to GCSL.BO's ROE of +0.09%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to GCSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check GCSL.BO's competition here
ASSAMENT.BO vs MASTERTR.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, MASTERTR.BO has a market cap of 9.3B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while MASTERTR.BO trades at ₹74.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas MASTERTR.BO's P/E ratio is 4.72. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to MASTERTR.BO's ROE of +0.18%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to MASTERTR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check MASTERTR.BO's competition here
ASSAMENT.BO vs SYSTMTXC.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SYSTMTXC.BO has a market cap of 8.7B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SYSTMTXC.BO trades at ₹66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SYSTMTXC.BO's P/E ratio is 3.64. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SYSTMTXC.BO's ROE of +0.09%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SYSTMTXC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SYSTMTXC.BO's competition here
ASSAMENT.BO vs ARYAMAN.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ARYAMAN.BO has a market cap of 7.2B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ARYAMAN.BO trades at ₹585.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ARYAMAN.BO's P/E ratio is 27.45. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ARYAMAN.BO's ROE of +0.19%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ARYAMAN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ARYAMAN.BO's competition here
ASSAMENT.BO vs KIRANVYPAR.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, KIRANVYPAR.BO has a market cap of 5.2B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while KIRANVYPAR.BO trades at ₹194.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas KIRANVYPAR.BO's P/E ratio is 48.38. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to KIRANVYPAR.BO's ROE of +0.00%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to KIRANVYPAR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check KIRANVYPAR.BO's competition here
ASSAMENT.BO vs ARYACAPM.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ARYACAPM.BO has a market cap of 5.1B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ARYACAPM.BO trades at ₹406.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ARYACAPM.BO's P/E ratio is 18.26. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ARYACAPM.BO's ROE of +0.12%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ARYACAPM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ARYACAPM.BO's competition here
ASSAMENT.BO vs SRAMSET.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SRAMSET.BO has a market cap of 5B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SRAMSET.BO trades at ₹279.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SRAMSET.BO's P/E ratio is -32.19. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SRAMSET.BO's ROE of -0.18%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SRAMSET.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SRAMSET.BO's competition here
ASSAMENT.BO vs UCIL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, UCIL.BO has a market cap of 4.5B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while UCIL.BO trades at ₹102.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas UCIL.BO's P/E ratio is -30.05. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to UCIL.BO's ROE of +0.73%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to UCIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check UCIL.BO's competition here
ASSAMENT.BO vs IMCAP.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, IMCAP.BO has a market cap of 3.2B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while IMCAP.BO trades at ₹914.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas IMCAP.BO's P/E ratio is 229.89. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to IMCAP.BO's ROE of +0.29%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to IMCAP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check IMCAP.BO's competition here
ASSAMENT.BO vs ALSL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ALSL.BO has a market cap of 3B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ALSL.BO trades at ₹68.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ALSL.BO's P/E ratio is 48.51. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ALSL.BO's ROE of +0.08%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ALSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ALSL.BO's competition here
ASSAMENT.BO vs PHCAP.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, PHCAP.BO has a market cap of 3B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while PHCAP.BO trades at ₹998.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas PHCAP.BO's P/E ratio is 39.71. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to PHCAP.BO's ROE of +0.06%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to PHCAP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check PHCAP.BO's competition here
ASSAMENT.BO vs NIDHGRN.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, NIDHGRN.BO has a market cap of 2.9B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while NIDHGRN.BO trades at ₹369.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas NIDHGRN.BO's P/E ratio is 37.78. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to NIDHGRN.BO's ROE of +0.43%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to NIDHGRN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check NIDHGRN.BO's competition here
ASSAMENT.BO vs QUESTCAP.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, QUESTCAP.BO has a market cap of 2.8B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while QUESTCAP.BO trades at ₹285.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas QUESTCAP.BO's P/E ratio is 12.79. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to QUESTCAP.BO's ROE of +0.02%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to QUESTCAP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check QUESTCAP.BO's competition here
ASSAMENT.BO vs OIVL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, OIVL.BO has a market cap of 2.8B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while OIVL.BO trades at ₹5.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas OIVL.BO's P/E ratio is 8.38. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to OIVL.BO's ROE of +0.44%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to OIVL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check OIVL.BO's competition here
ASSAMENT.BO vs REGENCY.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, REGENCY.BO has a market cap of 2.8B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while REGENCY.BO trades at ₹39.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas REGENCY.BO's P/E ratio is 27.12. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to REGENCY.BO's ROE of +0.10%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to REGENCY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check REGENCY.BO's competition here
ASSAMENT.BO vs IVC.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, IVC.BO has a market cap of 2.6B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while IVC.BO trades at ₹8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas IVC.BO's P/E ratio is 67.40. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to IVC.BO's ROE of +0.02%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to IVC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check IVC.BO's competition here
ASSAMENT.BO vs IVC.NS Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, IVC.NS has a market cap of 2.6B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while IVC.NS trades at ₹8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas IVC.NS's P/E ratio is 67.32. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to IVC.NS's ROE of +0.02%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to IVC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check IVC.NS's competition here
ASSAMENT.BO vs SHARDUL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SHARDUL.BO has a market cap of 2.5B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SHARDUL.BO trades at ₹28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SHARDUL.BO's P/E ratio is 3.55. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SHARDUL.BO's ROE of -0.07%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SHARDUL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SHARDUL.BO's competition here
ASSAMENT.BO vs HAMPTON.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, HAMPTON.BO has a market cap of 2.5B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while HAMPTON.BO trades at ₹9.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas HAMPTON.BO's P/E ratio is -285.67. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to HAMPTON.BO's ROE of -0.09%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to HAMPTON.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check HAMPTON.BO's competition here
ASSAMENT.BO vs VISCO.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, VISCO.BO has a market cap of 2.2B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while VISCO.BO trades at ₹92.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas VISCO.BO's P/E ratio is 7.50. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to VISCO.BO's ROE of -0.08%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to VISCO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check VISCO.BO's competition here
ASSAMENT.BO vs TAMBOLIIN.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, TAMBOLIIN.BO has a market cap of 2.2B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while TAMBOLIIN.BO trades at ₹222.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas TAMBOLIIN.BO's P/E ratio is 24.89. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to TAMBOLIIN.BO's ROE of +0.08%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to TAMBOLIIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check TAMBOLIIN.BO's competition here
ASSAMENT.BO vs SODFC.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SODFC.BO has a market cap of 2.1B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SODFC.BO trades at ₹124.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SODFC.BO's P/E ratio is -1782.86. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SODFC.BO's ROE of +0.01%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SODFC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SODFC.BO's competition here
ASSAMENT.BO vs JHACC.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, JHACC.BO has a market cap of 1.9B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while JHACC.BO trades at ₹204.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas JHACC.BO's P/E ratio is 37.12. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to JHACC.BO's ROE of +0.05%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to JHACC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check JHACC.BO's competition here
ASSAMENT.BO vs CGFL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, CGFL.BO has a market cap of 1.7B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while CGFL.BO trades at ₹34.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas CGFL.BO's P/E ratio is 6.88. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to CGFL.BO's ROE of +0.27%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to CGFL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check CGFL.BO's competition here
ASSAMENT.BO vs PROFINC.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, PROFINC.BO has a market cap of 1.7B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while PROFINC.BO trades at ₹2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas PROFINC.BO's P/E ratio is 80.00. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to PROFINC.BO's ROE of -0.04%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to PROFINC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check PROFINC.BO's competition here
ASSAMENT.BO vs ARIHCAPM.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ARIHCAPM.BO has a market cap of 1.4B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ARIHCAPM.BO trades at ₹68.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ARIHCAPM.BO's P/E ratio is 8.17. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ARIHCAPM.BO's ROE of +0.09%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ARIHCAPM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ARIHCAPM.BO's competition here
ASSAMENT.BO vs KEYFINSERV.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, KEYFINSERV.BO has a market cap of 1.4B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while KEYFINSERV.BO trades at ₹261.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas KEYFINSERV.BO's P/E ratio is 14.29. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to KEYFINSERV.BO's ROE of +0.08%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to KEYFINSERV.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check KEYFINSERV.BO's competition here
ASSAMENT.BO vs LKPSEC.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, LKPSEC.BO has a market cap of 1.4B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while LKPSEC.BO trades at ₹17.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas LKPSEC.BO's P/E ratio is 23.24. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to LKPSEC.BO's ROE of +0.11%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to LKPSEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check LKPSEC.BO's competition here
ASSAMENT.BO vs UPSURGE.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, UPSURGE.BO has a market cap of 1.3B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while UPSURGE.BO trades at ₹62.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas UPSURGE.BO's P/E ratio is 37.51. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to UPSURGE.BO's ROE of +0.03%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to UPSURGE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check UPSURGE.BO's competition here
ASSAMENT.BO vs DHARNI.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, DHARNI.BO has a market cap of 1.3B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while DHARNI.BO trades at ₹65.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas DHARNI.BO's P/E ratio is 46.50. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to DHARNI.BO's ROE of +0.19%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to DHARNI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check DHARNI.BO's competition here
ASSAMENT.BO vs VGCL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, VGCL.BO has a market cap of 1.3B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while VGCL.BO trades at ₹55.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas VGCL.BO's P/E ratio is 19.13. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to VGCL.BO's ROE of +0.11%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to VGCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check VGCL.BO's competition here
ASSAMENT.BO vs SWASTIKA.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SWASTIKA.BO has a market cap of 1.3B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SWASTIKA.BO trades at ₹66.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SWASTIKA.BO's P/E ratio is 3.95. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SWASTIKA.BO's ROE of +0.11%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SWASTIKA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SWASTIKA.BO's competition here
ASSAMENT.BO vs INDUSFINL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, INDUSFINL.BO has a market cap of 1.2B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while INDUSFINL.BO trades at ₹136.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas INDUSFINL.BO's P/E ratio is 66.83. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to INDUSFINL.BO's ROE of +0.09%. Regarding short-term risk, ASSAMENT.BO and INDUSFINL.BO have similar daily volatility (0.00).Check INDUSFINL.BO's competition here
ASSAMENT.BO vs VISTARAMAR.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, VISTARAMAR.BO has a market cap of 1.2B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while VISTARAMAR.BO trades at ₹202.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas VISTARAMAR.BO's P/E ratio is 45.46. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to VISTARAMAR.BO's ROE of +0.20%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to VISTARAMAR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check VISTARAMAR.BO's competition here
ASSAMENT.BO vs SCL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SCL.BO has a market cap of 1.2B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SCL.BO trades at ₹0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SCL.BO's P/E ratio is 3.83. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SCL.BO's ROE of +0.03%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SCL.BO's competition here
ASSAMENT.BO vs ESCORP.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ESCORP.BO has a market cap of 1.2B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ESCORP.BO trades at ₹104.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ESCORP.BO's P/E ratio is 38.81. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ESCORP.BO's ROE of +0.03%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ESCORP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ESCORP.BO's competition here
ASSAMENT.BO vs PIONRINV.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, PIONRINV.BO has a market cap of 1.1B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while PIONRINV.BO trades at ₹91.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas PIONRINV.BO's P/E ratio is 31.18. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to PIONRINV.BO's ROE of +0.10%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to PIONRINV.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check PIONRINV.BO's competition here
ASSAMENT.BO vs NAYSAA.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, NAYSAA.BO has a market cap of 1.1B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while NAYSAA.BO trades at ₹307.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas NAYSAA.BO's P/E ratio is 379.26. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to NAYSAA.BO's ROE of +0.57%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to NAYSAA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check NAYSAA.BO's competition here
ASSAMENT.BO vs AARNAV.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, AARNAV.BO has a market cap of 1.1B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while AARNAV.BO trades at ₹24.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas AARNAV.BO's P/E ratio is 78.45. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to AARNAV.BO's ROE of +0.05%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to AARNAV.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check AARNAV.BO's competition here
ASSAMENT.BO vs TITANSEC.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, TITANSEC.BO has a market cap of 1B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while TITANSEC.BO trades at ₹42.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas TITANSEC.BO's P/E ratio is 8.40. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to TITANSEC.BO's ROE of +0.12%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to TITANSEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check TITANSEC.BO's competition here
ASSAMENT.BO vs ASITCFIN.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ASITCFIN.BO has a market cap of 1B. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ASITCFIN.BO trades at ₹120.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ASITCFIN.BO's P/E ratio is -11.56. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ASITCFIN.BO's ROE of -0.07%. Regarding short-term risk, ASSAMENT.BO and ASITCFIN.BO have similar daily volatility (0.00).Check ASITCFIN.BO's competition here
ASSAMENT.BO vs SAUMYA.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SAUMYA.BO has a market cap of 988M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SAUMYA.BO trades at ₹135.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SAUMYA.BO's P/E ratio is -22.56. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SAUMYA.BO's ROE of -0.04%. Regarding short-term risk, ASSAMENT.BO and SAUMYA.BO have similar daily volatility (0.00).Check SAUMYA.BO's competition here
ASSAMENT.BO vs MUNCAPM.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, MUNCAPM.BO has a market cap of 951.4M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while MUNCAPM.BO trades at ₹103.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas MUNCAPM.BO's P/E ratio is -546.32. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to MUNCAPM.BO's ROE of -0.03%. Regarding short-term risk, ASSAMENT.BO and MUNCAPM.BO have similar daily volatility (0.00).Check MUNCAPM.BO's competition here
ASSAMENT.BO vs MUKESHB.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, MUKESHB.BO has a market cap of 885M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while MUKESHB.BO trades at ₹126.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas MUKESHB.BO's P/E ratio is -52.46. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to MUKESHB.BO's ROE of +0.02%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to MUKESHB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check MUKESHB.BO's competition here
ASSAMENT.BO vs GOWRALE.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, GOWRALE.BO has a market cap of 876M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while GOWRALE.BO trades at ₹107.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas GOWRALE.BO's P/E ratio is 11.93. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to GOWRALE.BO's ROE of +0.16%. Regarding short-term risk, ASSAMENT.BO and GOWRALE.BO have similar daily volatility (0.00).Check GOWRALE.BO's competition here
ASSAMENT.BO vs WALLFORT.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, WALLFORT.BO has a market cap of 802.6M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while WALLFORT.BO trades at ₹85.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas WALLFORT.BO's P/E ratio is -8.21. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to WALLFORT.BO's ROE of -0.02%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to WALLFORT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check WALLFORT.BO's competition here
ASSAMENT.BO vs CHRTEDCA.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, CHRTEDCA.BO has a market cap of 794.9M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while CHRTEDCA.BO trades at ₹267.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas CHRTEDCA.BO's P/E ratio is 29.36. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to CHRTEDCA.BO's ROE of +0.02%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to CHRTEDCA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check CHRTEDCA.BO's competition here
ASSAMENT.BO vs ADVIKCA.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ADVIKCA.BO has a market cap of 772.8M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ADVIKCA.BO trades at ₹1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ADVIKCA.BO's P/E ratio is 7.72. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ADVIKCA.BO's ROE of -0.10%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ADVIKCA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ADVIKCA.BO's competition here
ASSAMENT.BO vs SKPSEC.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SKPSEC.BO has a market cap of 733.3M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SKPSEC.BO trades at ₹112.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SKPSEC.BO's P/E ratio is 24.48. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SKPSEC.BO's ROE of +0.19%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SKPSEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SKPSEC.BO's competition here
ASSAMENT.BO vs GOGIACAP.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, GOGIACAP.BO has a market cap of 719M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while GOGIACAP.BO trades at ₹113.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas GOGIACAP.BO's P/E ratio is -2.98. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to GOGIACAP.BO's ROE of -0.01%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to GOGIACAP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check GOGIACAP.BO's competition here
ASSAMENT.BO vs ELIXIR.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ELIXIR.BO has a market cap of 697.8M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ELIXIR.BO trades at ₹119.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ELIXIR.BO's P/E ratio is 22.95. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ELIXIR.BO's ROE of +0.05%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ELIXIR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ELIXIR.BO's competition here
ASSAMENT.BO vs ROYALIND.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ROYALIND.BO has a market cap of 696M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ROYALIND.BO trades at ₹5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ROYALIND.BO's P/E ratio is -3.64. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ROYALIND.BO's ROE of +0.53%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ROYALIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ROYALIND.BO's competition here
ASSAMENT.BO vs MYMONEY.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, MYMONEY.BO has a market cap of 680.2M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while MYMONEY.BO trades at ₹41.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas MYMONEY.BO's P/E ratio is 16.20. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to MYMONEY.BO's ROE of +0.15%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to MYMONEY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check MYMONEY.BO's competition here
ASSAMENT.BO vs BAMPSL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, BAMPSL.BO has a market cap of 676.6M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while BAMPSL.BO trades at ₹19.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas BAMPSL.BO's P/E ratio is 473.33. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to BAMPSL.BO's ROE of +0.00%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to BAMPSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check BAMPSL.BO's competition here
ASSAMENT.BO vs JOINDRE.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, JOINDRE.BO has a market cap of 661M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while JOINDRE.BO trades at ₹47.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas JOINDRE.BO's P/E ratio is 36.75. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to JOINDRE.BO's ROE of +0.17%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to JOINDRE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check JOINDRE.BO's competition here
ASSAMENT.BO vs TFL.NS Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, TFL.NS has a market cap of 654.8M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while TFL.NS trades at ₹12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas TFL.NS's P/E ratio is -18.08. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to TFL.NS's ROE of -0.14%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to TFL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check TFL.NS's competition here
ASSAMENT.BO vs HBPOR.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, HBPOR.BO has a market cap of 595.5M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while HBPOR.BO trades at ₹57.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas HBPOR.BO's P/E ratio is -25.97. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to HBPOR.BO's ROE of +0.00%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to HBPOR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check HBPOR.BO's competition here
ASSAMENT.BO vs DHANCOT.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, DHANCOT.BO has a market cap of 528.5M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while DHANCOT.BO trades at ₹108.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas DHANCOT.BO's P/E ratio is 638.24. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to DHANCOT.BO's ROE of +0.00%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to DHANCOT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check DHANCOT.BO's competition here
ASSAMENT.BO vs LADDERUP.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, LADDERUP.BO has a market cap of 514.4M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while LADDERUP.BO trades at ₹50.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas LADDERUP.BO's P/E ratio is 58.46. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to LADDERUP.BO's ROE of +0.05%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to LADDERUP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check LADDERUP.BO's competition here
ASSAMENT.BO vs ISLCONSUL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ISLCONSUL.BO has a market cap of 510M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ISLCONSUL.BO trades at ₹21.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ISLCONSUL.BO's P/E ratio is 27.96. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ISLCONSUL.BO's ROE of -0.16%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ISLCONSUL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ISLCONSUL.BO's competition here
ASSAMENT.BO vs BRIDGESE.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, BRIDGESE.BO has a market cap of 486M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while BRIDGESE.BO trades at ₹15.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas BRIDGESE.BO's P/E ratio is 25.93. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to BRIDGESE.BO's ROE of +0.37%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to BRIDGESE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check BRIDGESE.BO's competition here
ASSAMENT.BO vs SMIFS.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SMIFS.BO has a market cap of 479.7M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SMIFS.BO trades at ₹81.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SMIFS.BO's P/E ratio is 41.44. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SMIFS.BO's ROE of +0.01%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SMIFS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SMIFS.BO's competition here
ASSAMENT.BO vs MEAPL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, MEAPL.BO has a market cap of 468.9M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while MEAPL.BO trades at ₹30.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas MEAPL.BO's P/E ratio is 2.75. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to MEAPL.BO's ROE of +0.31%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to MEAPL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check MEAPL.BO's competition here
ASSAMENT.BO vs MEFCOMCAP.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, MEFCOMCAP.BO has a market cap of 449.2M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while MEFCOMCAP.BO trades at ₹9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas MEFCOMCAP.BO's P/E ratio is 13.23. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to MEFCOMCAP.BO's ROE of -0.10%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to MEFCOMCAP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check MEFCOMCAP.BO's competition here
ASSAMENT.BO vs SRESTHA.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SRESTHA.BO has a market cap of 439.4M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SRESTHA.BO trades at ₹0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SRESTHA.BO's P/E ratio is -1.19. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SRESTHA.BO's ROE of -0.14%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SRESTHA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SRESTHA.BO's competition here
ASSAMENT.BO vs SAICAPI.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SAICAPI.BO has a market cap of 435.6M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SAICAPI.BO trades at ₹147.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SAICAPI.BO's P/E ratio is 3.47. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SAICAPI.BO's ROE of +0.03%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SAICAPI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SAICAPI.BO's competition here
ASSAMENT.BO vs SITAENT.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SITAENT.BO has a market cap of 432.3M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SITAENT.BO trades at ₹142.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SITAENT.BO's P/E ratio is -139.90. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SITAENT.BO's ROE of +0.26%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SITAENT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SITAENT.BO's competition here
ASSAMENT.BO vs NAM.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, NAM.BO has a market cap of 395.1M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while NAM.BO trades at ₹73.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas NAM.BO's P/E ratio is 293.08. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to NAM.BO's ROE of +0.01%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to NAM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check NAM.BO's competition here
ASSAMENT.BO vs KIDUJA.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, KIDUJA.BO has a market cap of 390.5M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while KIDUJA.BO trades at ₹16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas KIDUJA.BO's P/E ratio is 17.49. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to KIDUJA.BO's ROE of -0.10%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to KIDUJA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check KIDUJA.BO's competition here
ASSAMENT.BO vs SHRINIWAS.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SHRINIWAS.BO has a market cap of 388.2M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SHRINIWAS.BO trades at ₹12.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SHRINIWAS.BO's P/E ratio is 0.05. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SHRINIWAS.BO's ROE of -1.70%. Regarding short-term risk, ASSAMENT.BO and SHRINIWAS.BO have similar daily volatility (0.00).Check SHRINIWAS.BO's competition here
ASSAMENT.BO vs PANINDIAC.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, PANINDIAC.BO has a market cap of 385.7M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while PANINDIAC.BO trades at ₹1.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas PANINDIAC.BO's P/E ratio is 1125.00. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to PANINDIAC.BO's ROE of -0.06%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to PANINDIAC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check PANINDIAC.BO's competition here
ASSAMENT.BO vs ANUPAM.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ANUPAM.BO has a market cap of 373.8M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ANUPAM.BO trades at ₹1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ANUPAM.BO's P/E ratio is 19.70. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ANUPAM.BO's ROE of +0.07%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ANUPAM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ANUPAM.BO's competition here
ASSAMENT.BO vs AJCON.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, AJCON.BO has a market cap of 367M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while AJCON.BO trades at ₹6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas AJCON.BO's P/E ratio is 6.74. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to AJCON.BO's ROE of +0.01%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to AJCON.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check AJCON.BO's competition here
ASSAMENT.BO vs HBSL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, HBSL.BO has a market cap of 351.4M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while HBSL.BO trades at ₹50.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas HBSL.BO's P/E ratio is -3.33. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to HBSL.BO's ROE of -0.12%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to HBSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check HBSL.BO's competition here
ASSAMENT.BO vs 21STCENMGM.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, 21STCENMGM.BO has a market cap of 340.9M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while 21STCENMGM.BO trades at ₹32.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas 21STCENMGM.BO's P/E ratio is -1.44. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to 21STCENMGM.BO's ROE of -0.53%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to 21STCENMGM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check 21STCENMGM.BO's competition here
ASSAMENT.BO vs GOLDLINE.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, GOLDLINE.BO has a market cap of 317.8M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while GOLDLINE.BO trades at ₹0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas GOLDLINE.BO's P/E ratio is 610.00. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to GOLDLINE.BO's ROE of +0.00%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to GOLDLINE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check GOLDLINE.BO's competition here
ASSAMENT.BO vs SPCAPIT.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SPCAPIT.BO has a market cap of 315.9M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SPCAPIT.BO trades at ₹53.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SPCAPIT.BO's P/E ratio is -11.98. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SPCAPIT.BO's ROE of +0.12%. Regarding short-term risk, ASSAMENT.BO and SPCAPIT.BO have similar daily volatility (0.00).Check SPCAPIT.BO's competition here
ASSAMENT.BO vs ARNOLD.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ARNOLD.BO has a market cap of 315.5M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ARNOLD.BO trades at ₹13.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ARNOLD.BO's P/E ratio is -4.96. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ARNOLD.BO's ROE of +0.06%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ARNOLD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ARNOLD.BO's competition here
ASSAMENT.BO vs SUMEDHA.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SUMEDHA.BO has a market cap of 308.6M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SUMEDHA.BO trades at ₹38.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SUMEDHA.BO's P/E ratio is 12.76. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SUMEDHA.BO's ROE of +0.04%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SUMEDHA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SUMEDHA.BO's competition here
ASSAMENT.BO vs GALACTICO.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, GALACTICO.BO has a market cap of 295.6M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while GALACTICO.BO trades at ₹2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas GALACTICO.BO's P/E ratio is 18.55. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to GALACTICO.BO's ROE of +0.04%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to GALACTICO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check GALACTICO.BO's competition here
ASSAMENT.BO vs BERVINL.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, BERVINL.BO has a market cap of 282.5M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while BERVINL.BO trades at ₹47.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas BERVINL.BO's P/E ratio is -1.80. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to BERVINL.BO's ROE of -0.71%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to BERVINL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check BERVINL.BO's competition here
ASSAMENT.BO vs BIOGEN.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, BIOGEN.BO has a market cap of 279.8M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while BIOGEN.BO trades at ₹0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas BIOGEN.BO's P/E ratio is 31.00. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to BIOGEN.BO's ROE of +0.01%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to BIOGEN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check BIOGEN.BO's competition here
ASSAMENT.BO vs SULABEN.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, SULABEN.BO has a market cap of 276.3M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while SULABEN.BO trades at ₹2.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas SULABEN.BO's P/E ratio is 175.16. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to SULABEN.BO's ROE of +0.04%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to SULABEN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check SULABEN.BO's competition here
ASSAMENT.BO vs ABHIFIN.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ABHIFIN.BO has a market cap of 275.8M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ABHIFIN.BO trades at ₹62.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ABHIFIN.BO's P/E ratio is 275.45. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ABHIFIN.BO's ROE of +0.01%. Regarding short-term risk, ASSAMENT.BO and ABHIFIN.BO have similar daily volatility (0.00).Check ABHIFIN.BO's competition here
ASSAMENT.BO vs PHOTON.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, PHOTON.BO has a market cap of 275.5M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while PHOTON.BO trades at ₹186.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas PHOTON.BO's P/E ratio is 34.55. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to PHOTON.BO's ROE of +0.08%. Regarding short-term risk, ASSAMENT.BO and PHOTON.BO have similar daily volatility (0.00).Check PHOTON.BO's competition here
ASSAMENT.BO vs STANROS.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, STANROS.BO has a market cap of 274.4M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while STANROS.BO trades at ₹66.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas STANROS.BO's P/E ratio is -10.72. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to STANROS.BO's ROE of -0.08%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to STANROS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check STANROS.BO's competition here
ASSAMENT.BO vs RAMSONS.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, RAMSONS.BO has a market cap of 272.7M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while RAMSONS.BO trades at ₹91.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas RAMSONS.BO's P/E ratio is 3.61. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to RAMSONS.BO's ROE of +0.41%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to RAMSONS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check RAMSONS.BO's competition here
ASSAMENT.BO vs INDIANVSH.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, INDIANVSH.BO has a market cap of 265M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while INDIANVSH.BO trades at ₹7.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas INDIANVSH.BO's P/E ratio is -3.25. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to INDIANVSH.BO's ROE of +0.22%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to INDIANVSH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check INDIANVSH.BO's competition here
ASSAMENT.BO vs KJMCFIN.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, KJMCFIN.BO has a market cap of 258.7M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while KJMCFIN.BO trades at ₹55.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas KJMCFIN.BO's P/E ratio is 15.14. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to KJMCFIN.BO's ROE of +0.01%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to KJMCFIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check KJMCFIN.BO's competition here
ASSAMENT.BO vs ARUNIS.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, ARUNIS.BO has a market cap of 253.4M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while ARUNIS.BO trades at ₹85.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas ARUNIS.BO's P/E ratio is 49.39. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to ARUNIS.BO's ROE of +0.37%. Regarding short-term risk, ASSAMENT.BO is less volatile compared to ARUNIS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ASSAMENT.BO.Check ARUNIS.BO's competition here
ASSAMENT.BO vs PURSHOTTAM.BO Comparison July 2026
ASSAMENT.BO plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ASSAMENT.BO stands at 907.7M. In comparison, PURSHOTTAM.BO has a market cap of 241.3M. Regarding current trading prices, ASSAMENT.BO is priced at ₹661.95, while PURSHOTTAM.BO trades at ₹35.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ASSAMENT.BO currently has a P/E ratio of 31.44, whereas PURSHOTTAM.BO's P/E ratio is -13.43. In terms of profitability, ASSAMENT.BO's ROE is +0.03%, compared to PURSHOTTAM.BO's ROE of -0.03%. Regarding short-term risk, ASSAMENT.BO and PURSHOTTAM.BO have similar daily volatility (0.00).Check PURSHOTTAM.BO's competition here